Shanghai Pharmaceuticals To Renew Framework Agreement With Yunnan Baiyao

About this update from Yunnan Baiyao Group Co. Ltd. Class A

Shanghai Pharmaceuticals Holding Co Ltd SSE:601607:SAYS IT PLANS TO RENEW FRAMEWORK AGREEMENT WITH YUNNAN BAIYAO GROUP CO LTD, WITH SALES TO YUNNAN BAIYAO CAPPED AT 1.2 BILLION YUAN ($171.21 million), PURCHASES CAPPED AT 700 MILLION YUAN FOR 2026($1 = 7.0088 Chinese yuan renminbi)

View stock analysis, news, and events for Yunnan Baiyao Group Co. Ltd. Class A